Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension

por Mohammadi, Asma, Matos, Wanessa F, Intriago, Cesar, Thakkar, Keval, Jahan, Nasrin, Shah, Heeya, Nishu, Rifath I, Marzban, Sima
Publicado 2021

Post-COVID-19 Pulmonary Fibrosis

por Mohammadi, Asma, Balan, Irina, Yadav, Shikha, Matos, Wanessa F, Kharawala, Amrin, Gaddam, Mrunanjali, Sarabia, Noemi, Koneru, Sri Charitha, Suddapalli, Siva K, Marzban, Sima
Publicado 2022

Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system

por Wei, Qi, Mease, Philip J., Chiorean, Michael, Iles-Shih, Lulu, Matos, Wanessa F., Baumgartner, Andrew, Molani, Sevda, Hwang, Yeon Mi, Belhu, Basazin, Ralevski, Alexandra, Hadlock, Jennifer
Publicado 2023

Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping

por Duvvuri, Venkata R., Baumgartner, Andrew, Molani, Sevda, Hernandez, Patricia V., Yuan, Dan, Roper, Ryan T., Matos, Wanessa F., Robinson, Max, Su, Yapeng, Subramanian, Naeha, Goldman, Jason D., Heath, James R., Hadlock, Jennifer J.
Publicado 2022